Global Measures of Peripheral Blood-Derived DNA Methylation as a Risk Factor in the Development of Mature B-Cell Neoplasms
Lists
Only you see this
Abstract
Aberrant global DNA methylation is detectable in peripheral blood collected years before diagnosis and is associated with increased risk of MBCN, suggesting changes to DNA methylation are an early event in MBCN development.
BibTeX
@inproceedings{doo2015global,
author = {Nicole Wong Doo and Enes Makalic and Jihoon E. Joo and Claire M. Vajdic and Daniel F. Schmidt and Ee Ming Wong and Chol‐Hee Jung and Gianluca Severi and Daniel J. Park and Jessica Chung and Laura Baglietto and H. Miles Prince and John F. Seymour and Constantine S. Tam and John L. Hopper and Dallas R. English and Roger L. Milne and Simon J. Harrison and Melissa C. Southey and Graham G. Giles},
title = {{Global Measures of Peripheral Blood-Derived DNA Methylation as a Risk Factor in the Development of Mature B-Cell Neoplasms}},
booktitle = {Epigenomics},
year = {2015},
doi = {10.2217/epi.15.97},
}Loading related content...